Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 1

Interventions

Imatinib Mesylate 28 nilotinib 21 Cytarabine 21 Methotrexate 16 Hydroxyurea 15 Cyclophosphamide 15 Busulfan 15 Peripheral Blood Stem Cell Transplantation 13 ruxolitinib 11 Etoposide 11 Whole-Body Irradiation 10 fludarabine phosphate 9 fludarabine 9 Tacrolimus 9 Mycophenolic Acid 9 Daunorubicin 9 Idarubicin 8 Radiotherapy 7 Mitoxantrone 7 Interferon-alpha 7 Cyclosporine 6 peginterferon alfa-2a 5 bosutinib 5 asciminib 5 Melphalan 5 Azacitidine 5 merphos 4 luspatercept 4 Thioguanine 4 Filgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hydroxyzine × Myeloid × Clear all

NCT03808805 2025-12-03

APHYPAP

University Hospital, Brest

Phase 3 Completed

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡